GEORG MEISSNER APPOINTED AS CEO OF MEDIRACER AND HEAD INSTRUMENTS

Georg Meissner started as a CEO in Mediracer Ltd. and Head Instruments Ltd. at the end of April. Before this he has worked at Specim, Spectral Imaging Oy, as Managing Director and has lead the company successfully to a substantial growth. Prior to this he worked at...

GEORG MEISSNER MEDIRACERIN TOIMITUSJOHTAJAKSI

Georg Meissner started as a CEO in Mediracer Ltd. and Head Instruments Ltd. at the end of April. Before this he has worked at Specim, Spectral Imaging Oy, as Managing Director and has lead the company successfully to a substantial growth. Prior to this he worked at...

GEORG MEISSNER APPOINTED AS MEDIRACER CEO

Georg Meissner started as a CEO in Mediracer Ltd. and Head Instruments Ltd. at the end of April. Before this he has worked at Specim, Spectral Imaging Oy, as Managing Director and has lead the company successfully to a substantial growth. Prior to this he worked at...

神経伝導検査システム Mediracer® NCS 新解析ソフトウェアのお知らせ

新しいWindows版(OS 10)Mediracer検査のソフトウェアは、快適なユーザーインターフェイスと、迅速な検査プロセスにより、先生方への多くの利点をもたらし、新たな遠隔解析ソリューションとともに、神経生理学医による検査結果の解析をローカルに提供することが可能です。 新しいMediracerソフトウェアの機能は次の通りです: 〇 Windowsプラットフォームは、データの処理や転送が容易です。 〇 データの保存や印刷を、組織内の複数のコンピュータにプログラムをインストールしてご活用頂けます。 〇...

Arab Health 2018

29 tammikuuta – 1 helmikuuta Mediracer on mukana Arab Health 2018 tapahtumassa Dubaissa. Tule tapaamaan meitä Suomi-paviljonkiin, halli 3 / A10 ! Lisää Arab Health 2018 -tapahtumasta

Arab Health 2018

January 29-February 1 Mediracer will attend Arab Health 2018 exhibition in Dubai. Co,e and meet us at the Finnish Pavilion, Hall 3/ A10! Read more about Arab Health 2018 exhibition and congress